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Abstract
Objective—To assess the use of cervical mucus monitoring (CMM) in women trying to conceive




Patient(s)—Three hundred thirty-one women trying to conceive, ages 30 to 44 years, without
known infertility
Intervention(s)—None.
Main Outcome Measure(s)—CMM prevalence and fecundability.
Result(s)—During the first cycle of the study, CMM was performed consistently (checked on
>66% of pertinent cycle days) by 20 women (6%), inconsistently (34% to 66% of days) by 60
women (18%), infrequently (≤ 33% of days) by 73 women (22%), and not performed by 178
women (54%). Cycles in which CMM was consistently performed were statistically significantly
more likely to result in conception after adjusting for age, race, previous pregnancy, body mass
index, intercourse frequency, and urinary luteinizing hormone (LH) monitoring. Fecundability
also increased with increasing consistency of CMM.
Conclusion(s)—Among women trying to conceive, CMM is uncommon, but our study suggests
that CMM–a free, self-directed method to determine the fertile window–is associated with
increased fecundability independent of intercourse frequency or use of urinary LH monitoring.
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Timed intercourse during the 6-day window before and including the day of ovulation (the
fertile window) is significantly more likely to result in conception (1, 2). In the United
States, it has been estimated that over 7 million women have sought professional fertility
treatment, and almost 450,000 of those women sought medical care for advice on topics
such as detecting the fertile window and optimizing intercourse timing (3, 4). Because the
duration of the luteal phase is relatively stable, the days of the fertile window can be
estimated based on historical cycle length (5). In addition, a variety of self-administered
methods based on symptoms or biomarkers have been developed to assist in the prospective
detection of ovulation and the fertile window (4).
Urinary luteinizing hormone (LH) monitoring is one such method that is commonly used to
detect ovulation; however, this method can be expensive. Urinary LH monitoring alone
results in false-positive results in approximately 7% of cycles in an infertile population (6),
and it does not allow for prospective determination of the entire fertile window (7). Basal
body temperature (BBT) monitoring is another frequently used method; however, the
temperature change may be difficult to define, and the fertile window can only be defined
retrospectively (8–10).
Cervical mucus monitoring (CMM), a prospective method to detect the fertile window, is
performed via vulvar observations (excluding days of menstrual flow). Internal checking of
the vagina or cervix is not required. The cervical mucus (CM) is easily classified based upon
appearance and sensation. Types 1 and 2 CM are typically present at the beginning of the
menstrual cycle and are associated with dry (type 1) or damp (type 2) sensations at the
vulva. Type 3 is typically characterized by thick, creamy, and whitish or yellowish CM and
a damp sensation at the vulva. Type 4 is characterized by transparent and stretchy or elastic
CM (reminiscent of raw egg whites) and a wet or slippery sensation at the vulva (11).
Several studies have demonstrated that CMM is an excellent method for predicting
conception probabilities. Intercourse on a day with type 4 CM results in the highest
probability of conception and type 1 the lowest (11–15). An act of sexual intercourse
occurring on a day with type 4 CM is at least two to three times more likely to result in
conception than intercourse on a day with types 1 or 2 (14).
Previous trials of CMM have included at least one face-to-face training session regarding
monitoring. These studies have examined the predictive value of a given type of CM, but
none have determined whether using CMM improves the timing of intercourse or shortens
the time to pregnancy. Furthermore, CMM prevalence has not been assessed in an untrained,
noninfertile population. Therefore, our study assessed the current prevalence and
consistency of CMM in a population of women trying to conceive and determined whether
CMM, without formal training, is associated with increased cycle-specific probability of
conception (fecundability).
Materials and Methods
Time to Conceive (TTC) is anongoing time-to-pregnancy study approved by the institutional
review board of the University of North Carolina (16). The cohort from which our subjects
were obtained included English-speaking women between 30 and 44 years of age who had
been trying to conceive for 3 months or less. The exclusion criteria included history of
infertility, polycystic ovary syndrome, pelvic inflammatory disease, endometriosis, prior
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pelvic radiation, or a history of infertility in the partner. After consent was obtained, eligible
women completed a self-reported, online baseline survey of demographics, height, weight,
and medical history—for both herself and her male partner—as well as behaviors including
tobacco, alcohol, and caffeine use. Women were also instructed on the use of an online daily
diary to record information on vaginal bleeding, intercourse, methods and results of testing
for the fertile window (if performed), as well as pregnancy test results.
Women who reported that they checked their CM on any given day were asked to choose
the type observed that day (according to the types 1 to 4, with the descriptions provided in
the previous section). Women were given no other instruction on CMM, were not required
to perform CMM, and were given no information about its potential utility for identifying
the fertile window or optimizing intercourse timing. Participants were asked to complete the
diary daily until their first positive pregnancy test or four months of completed charting if no
pregnancy occurred. After the fourth month the women were asked to complete a similar
diary only once per month for up to 12 months of enrollment or until pregnancy occurred.
The women were given free home pregnancy tests (sensitivity: 20 mIU human chorionic
gonadotropin/mL) and were instructed to use them at the time of a missed menses and
inform the study staff of a positive result.
Analysis
The TTC study did not require the collection of systematic biomarker or symptom data
across all women or all cycles in the study, so the fertile widow was estimated using
calendar calculations based on cycle length (5, 17). Ovulation was estimated to have
occurred 14 days before the first day of menses or the first positive home pregnancy test,
with the fertile window designated as extending from 5 days before to 3 days after the
estimated day of ovulation as defined previously. The use and frequency of CMM was
determined for each cycle by the women's responses in the daily diary. The percentage of
days of CMM from the first day after the cessation of menses through the end of the fertile
window was calculated for each woman in each cycle. Given that CMM varied across
cycles, each cycle for each woman was independently categorized as non-monitored (did not
record a CM score on any of the days from the first day after menses through the fertile
window), infrequently monitored (mucus checked on 1% to 33% of days), inconsistently
monitored (34% to 66% of days), or consistently monitored (>66% of days). Pregnancy was
defined by the first report of a positive home pregnancy test.
Pearson correlations, Kruskal-Wallis tests, and chisquare tests were used to compare
demographics and potential covariates (age, race, marital status, education level, smoking,
previous pregnancy, body mass index [BMI], intercourse frequency in the fertile window,
urinary LH monitoring, past hormonal contraception, partner age, partner race, partner BMI,
and partner education) between the categories of CMM during the first completed cycle in
the study.
The potential covariates were subsequently examined via bivariate analysis and likelihood
ratio testing. For the models, we included the covariates that were strongly associated with
fecundability in our study or that had been identified in multiple prior studies as related to
fecundability, even if these variables were not statistically significant in our study. Potential
covariates that were highly correlated with other predictors thought to have a greater
relevance (i.e., partner age is highly correlated with subject age) were excluded. Unadjusted
discrete-time survival models were subsequently created to assess the relationship between
the covariates and fecundability.
These models treated an attempt cycle as the time unit of interest, using the “discrete”
method to handle ties and account for differential attempt cycles at the time of study entry.
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Maternal age was collapsed into three categories for modeling (30–34, 35–37, and 38–44
years of age), partner age was dichotomized as <50 or ≥50 years of age, and BMI was
categorized into three groups (<25, 25.0–29.9, and ≥30 kg/m2).
A discrete time proportional hazards model with time-varying (cycle-specific) categories of
CMM, intercourse frequency, and urinary LH monitoring was created to analyze the effect
of CMM in a given cycle (as recorded in the daily diary) on the probability of pregnancy in
that cycle. This model accounts for both the right censoring and left truncation (due to
women enrolling in cycles 1, 2, 3, or 4 of their pregnancy attempt) present in the data. In this
model, a fecundability ratio (FR) less than 1.0 suggests reduced fecundability. The final
model included maternal age, race (non-Hispanic white or non-white), history of previous
pregnancy (dichotomized as any/none), maternal BMI (calculated using subject-reported
height and weight), and cycle-specific intercourse frequency during the fertile window
(percentage of days in the fertile window with intercourse). A model was created with an
interaction term to assess for potential effect modification by urinary LH testing, but the
interaction was found to be statistically nonsignificant and was excluded from the final
model.
Results
A total of 448 women were enrolled in the study between April 2008 and November 2011.
Seventy-four percent (n = 331) of the women completed the baseline survey and at least one
cycle of daily diaries and were therefore included in this analysis. There were no statistically
significant differences in the covariates examined in this study between the women who
completed the daily diaries and those who did not. Of the analysis cohort, 70% of women
were <35 years of age, 19% were 35–37 years, and 11% were 38 years or older. Participants
tended to be Caucasian (76%), highly educated (71% with a master's degree or PhD),
previously pregnant (57%), and of normal BMI (62%). Sixteen percent of participants were
obese (BMI ≥30) and 2% were underweight (BMI < 18.5). Twenty-three percent of the
women enrolled became pregnant during their first cycle; by 6 months of enrollment, at least
53% of the women had conceived.
During the first cycle in the study, 178 (54%) of the women did not use CMM, 73 (22%)
monitored infrequently, 60 (18%) monitored inconsistently, and 20 (6%) monitored
consistently. The women who performed CMM (in the first cycle) tended to be younger
(Pearson correlation of −0.14, P=.010) and were more likely to use urinary LH monitoring
(P=.01). Women performing consistent CMM were more likely to be nulligravid (P=.002).
There were no differences in regards to race, BMI, education, smoking, intercourse
frequency, or past hormonal contraceptive use (Table 1).
In subsequent cycles, 22% of the women increased the frequency of CMM, 37% decreased,
38% remained the same, and 3% both increased and decreased their frequency of CMM.
After excluding the women who had conceived in the first cycle and adjusting for baseline
CMM category, age, BMI, race, previous pregnancy, intercourse frequency, and LH use,
increasing CMM category was not statistically significantly associated with fecundability
(FR = 1.57, 95% CI, 0.75–3.31) where no change in CMM was the referent group. However,
this analysis was likely underpowered (only 240 women) to determine the association
between change in CMM category and fecundability. Across all cycles, CM was monitored
(including infrequent, inconsistent, and consistent categories) in 42% of cycles. Of all CM
observations, type 3 was the most commonly reported (40%) and type 4 the least (15%).
Twenty-five percent of observations were documented as type 1 CM and 20% as type 2.
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The unadjusted and adjusted fecundability ratios for consistency of CMM are presented in
Table 2. Cycles in which women consistently performed CMM were statistically
significantly more likely to result in conception after adjusting for age, race, previous
pregnancy, BMI, and LH monitoring (FR = 2.29; 95% confidence interval [CI], 1.22–4.32),
and they demonstrated higher cumulative pregnancy rates (Fig. 1) compared with the cycles
in which women did not perform CMM. The association between CMM and fecundability
did not differ among women who did or did not perform urinary LH monitoring (Pinteraction
= 0.9073; data presented in Supplemental Table 1, available online), and the benefit of
CMM remained after adjusting for intercourse frequency in the fertile window (FR = 2.32;
95% CI, 1.23–4.40). A trend of increasing fecundability with increasing frequency of CMM
was also noted (P=.01).
Discussion
In our study, we found that consistent CMM was an infrequently used method of detecting
the fertile window in highly educated, noninfertile women, 30 to 44 years of age, who were
trying to conceive. The women who performed CMM were on the younger side of our
participants, and they tended to be more frequent users of urinary LH monitoring. CMM was
associated with increased fecundability independent of the use of urinary LH monitoring and
intercourse frequency. Furthermore, there was a statistically significant dose response, with
the level of consistency of CMM being positively associated with increasing fecundability.
We found that any use of CMM (42% of participants) was more common than the use of
urinary LH (27%) or basal body temperature monitoring (30%) in our study; however,
consistent CMM was less common than the other methods. Our findings may be related to
our relatively older reproductive cohort; we found that CMM prevalence decreased with
increasing maternal age. Younger women who have not previously conceived may
proactively seek resources to improve fertility. Younger women are more frequent users of
the Internet in general, and are also more likely to participate in blogs, seek online support
groups, and use online social networking (18, 19), which gives them easy access to
information on CMM. Our cohort was highly educated, which has been implicated in
frequency of overall Internet use, although a large national survey of over 7,000 participants
found that age was the biggest predictor of blog, support group, and social networking use
(19). We did not, however, assess whether the women in our older reproductive cohort had
sought CMM resources. Although age was inversely associated with CMM, adjustment for
age in our models did not diminish the impact of CMM on fecundability.
Compared with the women who did not monitor, CMM was associated with increased
fecundability. Urinary LH monitoring combined with monitoring for urinary estrone
glucuronide has also been associated with increased odds of conception (OR 1.89; 95% CI,
1.24–2.89) and a shortened time to pregnancy (20, 21). The benefits of the combined
monitoring based on the ClearBlue Easy Fertility Monitor (CBEFM) were statistically
significant only during the early attempts to conceive (all less than 6 months) (20). Our
study also included women early in their attempts to conceive, so we cannot comment on the
benefits of CMM for women who are further along in their attempts. No trials have
compared the utility of urinary LH monitoring with CMM using time to pregnancy as the
outcome. A study comparing the CBEFM (formerly the ClearPlan Easy Fertility Monitor)
with CMM demonstrated that both methods were capable of identifying the days of peak
fertility; however, the CBEFM failed to identify the onset of the fertile window
approximately 40% of the time (22). Although women who performed CMM in our study
were more frequent users of urinary LH monitoring, the association between CMM and
fecundability did not differ between those who did or did not perform urinary LH
monitoring.
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Increasing consistency of CMM was also associated with increasing fecundability. Women
who performed inconsistent CMM were less likely to conceive than the women performing
consistent CMM. Thus, our findings support the recommendation that women monitor CM
on a daily basis outside of menstruation to determine the fertile window, to time intercourse,
and to maximize the probability of conception. Although one would presume that increasing
frequency of urinary LH monitoring is also associated with increasing fecundability, to our
knowledge this has not been assessed in any published studies.
Our study suggests that CMM reduces the time to pregnancy by improving the timing of
intercourse. The number of acts of intercourse in the fertile window (as defined by calendar
calculations) did not differ by use of CMM. This is in agreement with prior research
findings that CMM provides additional information above and beyond that available through
calendar calculations (14, 15), likely due to the fact that the timing of the fertile window
varies substantially even in women with normal menstrual cycles (23). We propose that
CMM is more effective for the timing of intercourse than the calendar method, as it allows
for the onset and duration of the fertile window to be determined prospectively (22). It is
also possible that the association between CMM and improved fecundability was due to
residual confounding, even though we adjusted for likely confounders such as age, previous
pregnancy, intercourse frequency, urinary LH monitoring, and BMI.
To our knowledge, ours is the first study to assess CMM use and efficacy in a noninfertile
population without formal CM training. The strengths of our study include the use of a daily
diary, which helped minimize recall bias. CMM was not included in the study literature or
instructions, and it was reported prospectively before pregnancy. Also, the standardized
protocol for pregnancy testing increased the likelihood and accuracy of outcome reporting.
Our study does have limitations. Although the women were not instructed on how to
perform CMM, the daily diary could be considered informative because it included a
description of each CM type. Furthermore, our study cohort was well educated, lacked
women of younger reproductive ages, and only included women early in their attempts to
conceive. Additionally, although the effect of alcohol and caffeine on female fertility has not
been clearly established, some studies have suggested detrimental effects on fertility,
potentially in a dose-dependent manner (24, 25). Our analysis did not adjust for alcohol or
caffeine consumption, potentially contributing to residual, unmeasured confounding.
However, our positive findings support the need for a randomized controlled trial of CMM
in women of all reproductive ages in the general population.
Our study demonstrates that although sporadic use of CMM is common, consistent CMM is
infrequent in a population of women trying to conceive. However, even without formal
training, consistent CMM was associated with increased fecundability independent of
intercourse frequency or urinary LH monitoring. This suggests that CMM—a free, self-
directed method used to detect the fertile window—could potentially be used alone to
increase fecundability. It is further possible that more widespread use of CMM could
potentially lower the incidence of infertility and the need for fertility services in the general
population.
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(A) Unadjusted, Kaplan-Meier curves with time varying CMM. (B) Adjusted, discrete-time
proportional hazards model using first cycle information on CMM, intercourse frequency
during the fertile window, and LH monitoring (P=.02).
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Table 2




Category of CMM FR 95% CI FR 95% CI
None Reference
Infrequent (≤33%) 1.05 (0.68, 1.62) 1.10 (0.71, 1.74)
Inconsistent (34–66%) 1.30 (0.79, 2.16) 1.36 (0.81, 2.30)
Consistent (>66%) 2.10 (1.16, 3.81) 2.32 (1.23, 4.40)
a
Adjusted for age, race, previous pregnancy, BMI, urinary LH monitoring, and intercourse frequency.
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